Consistent with previous studies, we found that 18F-PSMA-1007 PET/CT shows high tumor-to-background ratios (TBR) in lesions with prostate cancer (6), median TBR of 24.92 in local lesions with prostate cancer, median TBR of 13.30 in lymph node metastases and bone metastases with prostate cancer. This evidence concerns the gene FOLH1 and prostate cancer.